In men with Lynch syndrome, these MMR gene mutations increase the risk of prostate cancer by two to three times, even when these individuals were not diagnosed with hereditary non-polyposis colorectal cancer [79]. This evidence concerns the gene MRC1 and prostate carcinoma.